Try our beta test site

Safety of ICL670 vs. Deferoxamine in Sickle Cell Disease Patients With Iron Overload Due to Blood Transfusions

This study has been completed.
Sponsor:
Information provided by:
Novartis
ClinicalTrials.gov Identifier:
NCT00067080
First received: August 11, 2003
Last updated: November 16, 2016
Last verified: November 2016